QuickView for n 4- cyanophenyl)- 2-( 4-( 2, 3, 6, 7- tetrahydro- 2, 6- dioxo- 1, 3- dipropyl- 1h- purin- 8- yl)- phenoxy) acetamide

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for n 4- cyanophenyl)- 2-( 4-( 2, 3, 6, 7- tetrahydro- 2, 6- dioxo- 1, 3- dipropyl- 1h- purin- 8- yl)- phenoxy) acetamide

There were no clinical trials for n 4- cyanophenyl)- 2-( 4-( 2, 3, 6, 7- tetrahydro- 2, 6- dioxo- 1, 3- dipropyl- 1h- purin- 8- yl)- phenoxy) acetamide